{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "12775192", "DateCompleted": {"Year": "2003", "Month": "07", "Day": "28"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "09"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1172-7047", "JournalIssue": {"Volume": "17", "Issue": "8", "PubDate": {"Year": "2003"}}, "Title": "CNS drugs", "ISOAbbreviation": "CNS Drugs"}, "ArticleTitle": "Mechanism of action of St John's wort in depression : what is known?", "Pagination": {"StartPage": "539", "EndPage": "562", "MedlinePgn": "539-62"}, "Abstract": {"AbstractText": ["Extracts of Hypericum perforatum L. (St John's wort) are now successfully competing for status as a standard antidepressant therapy. Because of this, great effort has been devoted to identifying the active antidepressant compounds in the extract. From a phytochemical point of view, St John's wort is one of the best-investigated medicinal plants. A series of bioactive compounds has been detected in the crude material, namely flavonol derivatives, biflavones, proanthocyanidines, xanthones, phloroglucinols and naphthodianthrones. Although St John's wort has been subjected to extensive scientific studies in the last decade, there are still many open questions about its pharmacology and mechanism of action. Initial biochemical studies reported that St John's wort is only a weak inhibitor of monoamine oxidase-A and -B activity but that it inhibits the synaptosomal uptake of serotonin, dopamine and noradrenaline (norepinephrine) with approximately equal affinity. However, other in vitro binding assays carried out using St John's wort extract demonstrated significant affinity for adenosine, GABA(A), GABA(B) and glutamate receptors. In vivo St John's wort extract leads to a downregulation of beta-adrenergic receptors and an upregulation of serotonin 5-HT(2) receptors in the rat frontal cortex and causes changes in neurotransmitter concentrations in brain areas that are implicated in depression. In studies using the rat forced swimming test, an animal model of depression, St John's wort extracts induced a significant reduction of immobility. In other experimental models of depression, including acute and chronic forms of escape deficit induced by stressors, St John's wort extract was shown to protect rats from the consequences of unavoidable stress. Recent neuroendocrine studies suggest that St John's wort is involved in the regulation of genes that control hypothalamic-pituitary-adrenal axis function. With regard to the antidepressant effects of St John's wort extract, many of the pharmacological activities appear to be attributable to the naphthodianthrone hypericin, the phloroglucinol derivative hyperforin and several flavonoids. This review integrates new findings of possible mechanisms that may underlie the antidepressant action of St John's wort and its active constituents with a large body of existing literature."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Pharmacology and Toxicology, Universit\u00e4tsklinikum M\u00fcnster, M\u00fcnster, Germany. butterv@uni-muenster.de"}], "Identifier": [], "LastName": "Butterweck", "ForeName": "Veronika", "Initials": "V"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "CNS Drugs", "NlmUniqueID": "9431220", "ISSNLinking": "1172-7047"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antidepressive Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Biogenic Monoamines"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Neurotransmitter"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Antidepressive Agents"}, {"QualifierName": [], "DescriptorName": "Behavioral Medicine"}, {"QualifierName": ["agonists", "antagonists & inhibitors", "metabolism"], "DescriptorName": "Biogenic Monoamines"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Depression"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Hypericum"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Receptors, Neurotransmitter"}], "NumberOfReferences": "143"}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Biol Psychiatry. 1998 Dec 1;44(11):1128-42", "ArticleIdList": ["9836016"]}, {"Citation": "Clin Ther. 2000 Apr;22(4):411-9", "ArticleIdList": ["10823363"]}, {"Citation": "Mol Psychiatry. 2001 Sep;6(5):547-64", "ArticleIdList": ["11526469"]}, {"Citation": "Mol Pharmacol. 1992 Jun;41(6):1016-22", "ArticleIdList": ["1614406"]}, {"Citation": "Eur J Pharmacol. 1981 Jun 19;72(2-3):145-52", "ArticleIdList": ["7195816"]}, {"Citation": "Phytomedicine. 2001 Mar;8(2):152-60", "ArticleIdList": ["11315759"]}, {"Citation": "Adv Pharmacol. 1998;42:482-5", "ArticleIdList": ["9327944"]}, {"Citation": "Nature. 1975 Oct 9;257(5526):495-6", "ArticleIdList": ["170534"]}, {"Citation": "Pharmacopsychiatry. 1997 Sep;30 Suppl 2:72-6", "ArticleIdList": ["9342763"]}, {"Citation": "Nature. 1977 Aug 4;268(5619):455-6", "ArticleIdList": ["197419"]}, {"Citation": "Pharmacopsychiatry. 2000 Jan;33(1):14-8", "ArticleIdList": ["10721879"]}, {"Citation": "Commun Psychopharmacol. 1979;3(1):35-9", "ArticleIdList": ["466999"]}, {"Citation": "Planta Med. 2000 Feb;66(1):3-6", "ArticleIdList": ["10705724"]}, {"Citation": "J Clin Invest. 1991 Mar;87(3):831-7", "ArticleIdList": ["1671867"]}, {"Citation": "Pharmacopsychiatry. 2001 Jul;34 Suppl 1:S56-60", "ArticleIdList": ["11518078"]}, {"Citation": "J Pharmacol Exp Ther. 1999 Sep;290(3):1363-8", "ArticleIdList": ["10454515"]}, {"Citation": "Life Sci. 1998;63(6):499-510", "ArticleIdList": ["9718074"]}, {"Citation": "Pharmacol Ther. 1990;45(3):425-55", "ArticleIdList": ["2405444"]}, {"Citation": "Br J Psychiatry Suppl. 1992 Feb;(15):44-50", "ArticleIdList": ["1356357"]}, {"Citation": "Clin Neuropharmacol. 1993 Oct;16(5):387-400", "ArticleIdList": ["8221701"]}, {"Citation": "J Comp Neurol. 1995 Dec 4;363(1):15-27", "ArticleIdList": ["8682934"]}, {"Citation": "Biol Psychiatry. 1998 Apr 15;43(8):547-73", "ArticleIdList": ["9564441"]}, {"Citation": "Pol J Pharmacol. 1993 May-Jun;45(3):243-52", "ArticleIdList": ["8220658"]}, {"Citation": "Ann N Y Acad Sci. 1990;600:486-99; discussion 499-500", "ArticleIdList": ["2252328"]}, {"Citation": "Brain Res. 2002 Mar 15;930(1-2):21-9", "ArticleIdList": ["11879791"]}, {"Citation": "Biol Psychiatry. 1970 Oct;2(4):367-89", "ArticleIdList": ["4320227"]}, {"Citation": "Physiol Behav. 1982 Feb;28(2):307-11", "ArticleIdList": ["7079344"]}, {"Citation": "Ann N Y Acad Sci. 1990;600:68-78; discussion 79-80", "ArticleIdList": ["2252338"]}, {"Citation": "Pharmacopsychiatry. 2001 Jul;34 Suppl 1:S137-42", "ArticleIdList": ["11518063"]}, {"Citation": "Int Clin Psychopharmacol. 2000 Mar;15(2):61-8", "ArticleIdList": ["10759336"]}, {"Citation": "J Geriatr Psychiatry Neurol. 1994 Oct;7 Suppl 1:S57-9", "ArticleIdList": ["7857511"]}, {"Citation": "Psychopharmacol Bull. 1994;30(1):39-43", "ArticleIdList": ["7972628"]}, {"Citation": "Pharmacopsychiatry. 1997 Sep;30 Suppl 2:108-12", "ArticleIdList": ["9342770"]}, {"Citation": "Pharmacopsychiatry. 1997 Sep;30 Suppl 2:117-24", "ArticleIdList": ["9342772"]}, {"Citation": "Psychopharmacology (Berl). 1984;83(1):1-16", "ArticleIdList": ["6429692"]}, {"Citation": "Neuropsychopharmacology. 1999 Aug;21(2):247-57", "ArticleIdList": ["10432473"]}, {"Citation": "Psychopharmacology (Berl). 1990;101(3):403-7", "ArticleIdList": ["2362957"]}, {"Citation": "J Geriatr Psychiatry Neurol. 1994 Oct;7 Suppl 1:S54-6", "ArticleIdList": ["7857510"]}, {"Citation": "Neuropsychopharmacology. 2000 Aug;23 (2):188-97", "ArticleIdList": ["10882845"]}, {"Citation": "Arzneimittelforschung. 1995 Nov;45(11):1145-8", "ArticleIdList": ["8929227"]}, {"Citation": "J Geriatr Psychiatry Neurol. 1994 Oct;7 Suppl 1:S60-2", "ArticleIdList": ["7857513"]}, {"Citation": "Curr Opin Chem Biol. 1999 Aug;3(4):481-8", "ArticleIdList": ["10419849"]}, {"Citation": "Pharmacopsychiatry. 2001 Jul;34 Suppl 1:S26-8", "ArticleIdList": ["11518071"]}, {"Citation": "Naunyn Schmiedebergs Arch Pharmacol. 1999 Sep;360(3):262-9", "ArticleIdList": ["10543427"]}, {"Citation": "Biomed Pharmacother. 1996;50(1):7-12", "ArticleIdList": ["8672734"]}, {"Citation": "Pharmacol Biochem Behav. 2000 May;66(1):105-11", "ArticleIdList": ["10837849"]}, {"Citation": "Life Sci. 2001 Feb 23;68(14 ):1593-605", "ArticleIdList": ["11263672"]}, {"Citation": "Cell Mol Neurobiol. 1989 Mar;9(1):1-44", "ArticleIdList": ["2565769"]}, {"Citation": "Life Sci. 1999;65(22):2395-405", "ArticleIdList": ["10597894"]}, {"Citation": "Pharmacopsychiatry. 2001 Jul;34 Suppl 1:S103-7", "ArticleIdList": ["11518055"]}, {"Citation": "Endocr Rev. 1996 Apr;17(2):187-205", "ArticleIdList": ["8706631"]}, {"Citation": "J Comp Physiol Psychol. 1967 Feb;63(1):28-33", "ArticleIdList": ["6029715"]}, {"Citation": "Brain Res. 1993 Jun 25;615(1):87-94", "ArticleIdList": ["8364729"]}, {"Citation": "Eur J Pharmacol. 1978 Feb 15;47(4):379-91", "ArticleIdList": ["204499"]}, {"Citation": "Pharmacopsychiatry. 2000 Mar;33(2):60-5", "ArticleIdList": ["10761821"]}, {"Citation": "J Nat Prod. 1996 Feb;59(2):205-15", "ArticleIdList": ["8991956"]}, {"Citation": "Life Sci. 1998;62(16):PL265-70", "ArticleIdList": ["9585174"]}, {"Citation": "J Geriatr Psychiatry Neurol. 1994 Oct;7 Suppl 1:S6-8", "ArticleIdList": ["7857512"]}, {"Citation": "Pharmacol Biochem Behav. 1996 May;54(1):219-28", "ArticleIdList": ["8728561"]}, {"Citation": "Prog Brain Res. 1996;107:201-22", "ArticleIdList": ["8782521"]}, {"Citation": "Pharmacopsychiatry. 1998 Jun;31 Suppl 1:54-9", "ArticleIdList": ["9684948"]}, {"Citation": "Psychopharmacology (Berl). 2002 Jul;162(2):193-202", "ArticleIdList": ["12110997"]}, {"Citation": "Pharmacopsychiatry. 2001 Jul;34 Suppl 1:S42-4", "ArticleIdList": ["11518074"]}, {"Citation": "Synapse. 1993 Aug;14(4):324-31", "ArticleIdList": ["8248854"]}, {"Citation": "Eur J Pharmacol. 1979 Dec 7;60(2-3):139-42", "ArticleIdList": ["575094"]}, {"Citation": "Nature. 1977 Apr 21;266(5604):730-2", "ArticleIdList": ["559941"]}, {"Citation": "Pharmacopsychiatry. 1998 Jun;31 Suppl 1:16-21", "ArticleIdList": ["9684943"]}, {"Citation": "N Engl J Med. 1988 Aug 11;319(6):348-53", "ArticleIdList": ["3292920"]}, {"Citation": "J Neurochem. 1994 Jun;62(6):2262-8", "ArticleIdList": ["8189233"]}, {"Citation": "Trends Pharmacol Sci. 1994 Jul;15(7):220-6", "ArticleIdList": ["7940983"]}, {"Citation": "Arch Gen Psychiatry. 1981 Oct;38(10):1160-80", "ArticleIdList": ["6271089"]}, {"Citation": "Pharmacopsychiatry. 1997 Sep;30 Suppl 2:129-34", "ArticleIdList": ["9342774"]}, {"Citation": "Brain Res. 1992 Feb 14;572(1-2):117-25", "ArticleIdList": ["1351783"]}, {"Citation": "Pharmacopsychiatry. 1997 Sep;30 Suppl 2:113-6", "ArticleIdList": ["9342771"]}, {"Citation": "Pharmacopsychiatry. 1997 Sep;30 Suppl 2:125-8", "ArticleIdList": ["9342773"]}, {"Citation": "J Pharmacol Exp Ther. 2002 May;301(2):714-9", "ArticleIdList": ["11961077"]}, {"Citation": "JAMA. 2002 Apr 10;287(14):1807-14", "ArticleIdList": ["11939866"]}, {"Citation": "Pharmacopsychiatry. 2001 Jul;34 Suppl 1:S111-5", "ArticleIdList": ["11518058"]}, {"Citation": "Pharmacopsychiatry. 2001 Jul;34 Suppl 1:S98-102", "ArticleIdList": ["11518085"]}, {"Citation": "Pharmacopsychiatry. 2001 Jul;34 Suppl 1:S134-6", "ArticleIdList": ["11518062"]}, {"Citation": "J Pharm Pharmacol. 1999 Jun;51(6):723-8", "ArticleIdList": ["10454050"]}, {"Citation": "BMJ. 2000 Sep 2;321(7260):536-9", "ArticleIdList": ["10968813"]}, {"Citation": "Pharmacopsychiatry. 2001 Jul;34 Suppl 1:S74-82", "ArticleIdList": ["11518081"]}, {"Citation": "Eur J Pharmacol. 2000 Sep 29;405(1-3):351-63", "ArticleIdList": ["11033340"]}, {"Citation": "Planta Med. 1984 Jun;50(3):272-4", "ArticleIdList": ["6484033"]}, {"Citation": "Eur J Pharmacol. 1979 Oct 1;58(3):331-4", "ArticleIdList": ["510364"]}, {"Citation": "Pharmacopsychiatry. 2001 Jul;34 Suppl 1:S2-7", "ArticleIdList": ["11518068"]}, {"Citation": "Prog Brain Res. 1992;93:385-417", "ArticleIdList": ["1336204"]}, {"Citation": "Prog Neuropsychopharmacol Biol Psychiatry. 1987;11(1):1-7", "ArticleIdList": ["3602410"]}, {"Citation": "J Neural Transm Gen Sect. 1991;84(1-2):19-32", "ArticleIdList": ["1647168"]}, {"Citation": "Biol Psychiatry. 1999 Aug 15;46(4):581-4", "ArticleIdList": ["10459411"]}, {"Citation": "Pharmacopsychiatry. 2001 Jul;34 Suppl 1:S29-37", "ArticleIdList": ["11518072"]}, {"Citation": "Neuroendocrinology. 1994 Oct;60(4):436-44", "ArticleIdList": ["7824085"]}, {"Citation": "Trends Pharmacol Sci. 2002 May;23(5):238-45", "ArticleIdList": ["12008002"]}, {"Citation": "J Pharmacol Exp Ther. 1970 Nov;175(2):404-18", "ArticleIdList": ["5481708"]}, {"Citation": "J Clin Psychopharmacol. 1996 Jun;16(3 Suppl 2):1S-7S; discussion 7S-9S", "ArticleIdList": ["8784643"]}, {"Citation": "Trends Neurosci. 1995 Jan;18(1):6-11", "ArticleIdList": ["7535490"]}, {"Citation": "BMJ. 1996 Aug 3;313(7052):253-8", "ArticleIdList": ["8704532"]}, {"Citation": "Planta Med. 1998 May;64(4):291-4", "ArticleIdList": ["9619107"]}, {"Citation": "Pflugers Arch. 2000 Jul;440(3):427-34", "ArticleIdList": ["10954328"]}, {"Citation": "BMJ. 1999 Dec 11;319(7224):1534-8", "ArticleIdList": ["10591711"]}, {"Citation": "Pharmacopsychiatry. 1998 Jun;31 Suppl 1:36-43", "ArticleIdList": ["9684946"]}, {"Citation": "Pharmacopsychiatry. 1998 Jun;31 Suppl 1:7-15", "ArticleIdList": ["9684942"]}, {"Citation": "Pharm Acta Helv. 1997 Jun;72(3):153-7", "ArticleIdList": ["9204773"]}, {"Citation": "J Neuroendocrinol. 1992 Dec;4(6):689-99", "ArticleIdList": ["21554656"]}, {"Citation": "Pharmacopsychiatry. 2001 Jul;34 Suppl 1:S148-51", "ArticleIdList": ["11518066"]}, {"Citation": "Mol Pharmacol. 1971 Jan;7(1):66-80", "ArticleIdList": ["5552252"]}, {"Citation": "Eur Neuropsychopharmacol. 1999 Dec;9(6):461-8", "ArticleIdList": ["10625112"]}, {"Citation": "Neurosci Lett. 1999 Mar 12;262(3):199-202", "ArticleIdList": ["10218890"]}, {"Citation": "J Psychopharmacol. 2000;14(4):360-3", "ArticleIdList": ["11198053"]}, {"Citation": "Pharmacopsychiatry. 1997 Sep;30 Suppl 2:102-7", "ArticleIdList": ["9342769"]}, {"Citation": "Pharmacopsychiatry. 2001 Jul;34 Suppl 1:S45-8", "ArticleIdList": ["11518075"]}, {"Citation": "Neuropsychopharmacology. 2001 Dec;25(6):858-70", "ArticleIdList": ["11750179"]}, {"Citation": "Pharmacopsychiatry. 1997 Sep;30 Suppl 2:81-5", "ArticleIdList": ["9342765"]}, {"Citation": "Planta Med. 2002 Jan;68(1):88-91", "ArticleIdList": ["11842341"]}, {"Citation": "J Recept Signal Transduct Res. 1999 Jan-Jul;19(1-4):59-74", "ArticleIdList": ["10071750"]}, {"Citation": "Pharmacopsychiatry. 2001 Jul;34 Suppl 1:S119-26", "ArticleIdList": ["11518060"]}, {"Citation": "Pharmacol Biochem Behav. 1982 Mar;16(3):449-54", "ArticleIdList": ["7200610"]}, {"Citation": "Biochem Pharmacol. 1978 Feb 1;27(3):257-61", "ArticleIdList": ["202286"]}, {"Citation": "JAMA. 2001 Apr 18;285(15):1978-86", "ArticleIdList": ["11308434"]}, {"Citation": "Pharmacol Rev. 1985 Sep;37(3):249-332", "ArticleIdList": ["2869509"]}, {"Citation": "Annu Rev Neurosci. 1993;16:73-93", "ArticleIdList": ["8096377"]}, {"Citation": "Biochem Pharmacol. 1988 Sep 1;37(17):3285-7", "ArticleIdList": ["2840912"]}]}], "History": [{"Year": "2003", "Month": "5", "Day": "31", "Hour": "5", "Minute": "0"}, {"Year": "2003", "Month": "7", "Day": "29", "Hour": "5", "Minute": "0"}, {"Year": "2003", "Month": "5", "Day": "31", "Hour": "5", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["12775192", "10.2165/00023210-200317080-00001", "1781"]}}], "PubmedBookArticle": []}